The Next Big Thing in Biotech: Worst CEO Candidates
Adam Feuerstein, senior columnist for <I>TheStreet</I>, is assembling candidates for the Worst Biotech CEO of 2012 award.
Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback;
to send him an email.
Scroll to Continue
